Showing results (131-140 of 902) with videos related to

Sort By:
Pageof 91
NPJ Primary Care Respiratory Medicine|July 18, 2014
Exploring patients' views of primary care consultations with contrasting interventions for acute cough: a six-country European qualitative studySarah Tonkin-Crine, Sibyl Anthierens, Nick A Francis, et al.
Journal of Global Antimicrobial Resistance|May 8, 2024
Epidemiology and genetic diversity of linezolid-resistant Enterococcus clinical isolates in Belgium from 2013 to 2021Olivier Mortelé, Stefanie van Kleef-van Koeveringe, Sarah Vandamme, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 1, 2002
Strategies for selecting antibiotics in intensive care unitsHendrik E. Demey, Hilde Jansens, Frank Van Laer, et al.
Future Microbiology|May 17, 2021
COMBACTE LAB-Net: building a European laboratory network for clinical trials on anti-infectivesTomislav Kostyanev, Leen Timbermont, Tuba Vilken, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 4, 2020
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortagePasquale De Nardo, Elisa Gentilotti, Fulvia Mazzaferri, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in EuropeMatus Ferech, Samuel Coenen, Surbhi Malhotra-Kumar, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2007
Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement dataJosé Campos, Matus Ferech, Edurne Lázaro, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in EuropeMatus Ferech, Samuel Coenen, Surbhi Malhotra-Kumar, et al.
Genome Medicine|May 30, 2019
Associating somatic mutations to clinical outcomes: a pan-cancer study of survival timePaul Little, Dan-Yu Lin, Wei Sun
Pageof 91